L-Glycine

• Sleep quality improvement
• Cognitive function support
• Anti-inflammatory effects
• Antioxidant protection

• Supports collagen synthesis
• May improve joint health
• Contributes to glutathione production
• Supports muscle growth and recovery
• May help regulate blood sugar
• Potential neuroprotective effects

L-Glycine, the simplest amino acid in the human body, exerts its effects through multiple mechanisms spanning neurotransmission, structural protein formation, antioxidant pathways, and metabolic regulation. As a neurotransmitter in the central nervous system, glycine primarily functions as an inhibitory signal, particularly in the spinal cord and brainstem. It binds to strychnine-sensitive glycine receptors (GlyRs), which are ligand-gated chloride ion channels. When glycine binds to these receptors, it triggers an influx of chloride ions into neurons, causing hyperpolarization that reduces neuronal excitability.

This inhibitory action contributes to glycine’s calming, sleep-promoting, and neuroprotective properties. The sleep-enhancing effects of glycine also involve peripheral mechanisms, as it reduces core body temperature by dilating blood vessels in the extremities, which facilitates the onset of sleep. This thermoregulatory effect appears to be mediated through NMDA receptors in the suprachiasmatic nucleus, the brain’s primary circadian pacemaker. Paradoxically, glycine also serves as an obligatory co-agonist at excitatory N-methyl-D-aspartate (NMDA) glutamate receptors.

By binding to the glycine site on NMDA receptors, it facilitates glutamate signaling, which is crucial for synaptic plasticity, learning, and memory. This dual role in both inhibitory and excitatory neurotransmission allows glycine to help maintain the delicate balance of neural activity. In protein structure, glycine plays a unique role due to its minimal side chain (a single hydrogen atom). It serves as a key component in the triple helical structure of collagen, the most abundant protein in the human body.

Approximately one-third of collagen’s amino acid composition is glycine, occurring at every third position in the polypeptide chain. This regular spacing allows the collagen strands to form a tight triple helix, as glycine’s small size permits close packing of the chains. Without sufficient glycine, collagen synthesis is impaired, affecting skin, bone, cartilage, tendons, and other connective tissues. Glycine is also a critical component in the synthesis of glutathione, one of the body’s primary endogenous antioxidants.

As one of glutathione’s three constituent amino acids (along with cysteine and glutamic acid), glycine contributes to cellular protection against oxidative stress and detoxification processes. Adequate glycine levels are essential for maintaining glutathione homeostasis, particularly during periods of increased oxidative challenge. In metabolic pathways, glycine participates in numerous reactions. It serves as a key component in the glycine cleavage system, an important pathway for one-carbon metabolism that provides methyl groups for various synthetic reactions, including DNA and RNA synthesis.

Glycine is also involved in the synthesis of heme, the iron-containing component of hemoglobin and myoglobin. Additionally, it contributes to the formation of creatine, which is crucial for energy metabolism in muscle and brain tissues. Glycine plays a role in bile acid conjugation in the liver, facilitating the excretion of bile acids and supporting fat digestion. In the immune system, glycine exhibits anti-inflammatory properties through multiple mechanisms.

It inhibits the activation of inflammatory cells such as macrophages and neutrophils, reduces the production of pro-inflammatory cytokines, and suppresses the formation of free radicals in immune cells. These effects contribute to glycine’s potential benefits in conditions characterized by excessive inflammation. Glycine also influences insulin sensitivity and glucose metabolism. Research suggests it may help improve insulin signaling pathways, enhance glucose uptake in tissues, and protect pancreatic β-cells from damage.

These effects may contribute to glycine’s potential benefits in metabolic health. In the cardiovascular system, glycine has been shown to have cardioprotective effects, potentially by reducing oxidative stress, improving endothelial function, and modulating calcium handling in cardiac cells. It may also help regulate blood pressure through its effects on nitric oxide production and vascular tone. At the cellular level, glycine can act as an osmolyte, helping to regulate cell volume and protect against osmotic stress.

It also serves as a cytoprotective agent, potentially shielding cells from various forms of injury and stress. In summary, glycine’s diverse mechanisms of action—spanning neurotransmission, structural roles, antioxidant pathways, metabolic regulation, anti-inflammatory effects, and cytoprotection—underlie its wide range of physiological functions and potential therapeutic applications. This multifaceted profile explains why glycine supplementation may benefit sleep quality, cognitive function, inflammatory conditions, metabolic health, and connective tissue integrity.

Standard Range: 3-5 g daily

Maintenance Dose: 3 g daily for general health support

Therapeutic Dose: 5-15 g daily depending on condition

Timing: Varies by application; often taken before bedtime for sleep benefits

Cycling Recommendations: Generally not necessary; can be taken continuously

Established Ul: No officially established upper limit by regulatory agencies

Research Based Ul: Generally considered safe up to 90 g daily in divided doses for healthy adults under medical supervision

Toxicity Threshold: No clear toxicity threshold established; extremely high safety profile

Notes: Higher doses may increase risk of mild gastrointestinal side effects; very high doses (>30 g/day) should only be used under medical supervision

Optimal Timing: For sleep: 30-60 minutes before bedtime; For cognitive function: morning or early afternoon; For metabolic health: with or before meals; For muscle recovery: post-workout

Meal Effects: Taking on an empty stomach may improve absorption by avoiding competition with other amino acids; however, glycine is generally well-absorbed even with food

Circadian Considerations: Evening doses support sleep onset and quality; morning doses may support daytime cognitive function

Exercise Timing: Post-workout administration may support recovery and protein synthesis

Multiple Dose Scheduling: For doses >5 g daily, divide into 2-3 servings throughout the day for optimal utilization and tolerance

Typical Dietary Intake: Average adult consumes approximately 2-3 g daily through protein-rich foods

Food Sources Comparison: Dietary sources provide glycine bound in proteins, which is released gradually during digestion; supplements provide free-form glycine for more immediate availability

Dietary Vs Supplemental: Dietary sources sufficient for basic needs; supplementation may provide therapeutic benefits beyond typical dietary intake

Dietary Patterns: Low-protein diets may provide insufficient glycine; vegetarian/vegan diets may benefit from supplementation due to lower intake of glycine-rich animal proteins

Dosage Research Gaps: Optimal dosing for many conditions still being established; dose-response relationships not fully characterized

Population Specific Research: Limited research in pediatric populations and pregnant/lactating women

Methodological Challenges: Variations in study designs, populations, and outcome measures make direct comparisons difficult

Future Research Needs: More dose-response studies; better characterization of optimal timing; longer-term safety and efficacy data for chronic supplementation

Absorption Rate: Approximately 80-90% from oral supplements in healthy individuals

Absorption Site: Primarily in the small intestine via specific amino acid transporters

Absorption Mechanism: Transported across the intestinal epithelium via sodium-dependent transporters (primarily system GLYT1 and system B0) and sodium-independent transporters

Factors Affecting Absorption: Presence of other amino acids (competitive inhibition), Gastrointestinal health (inflammation may reduce absorption), Dosage (higher single doses may saturate transporters), Form of glycine (free vs. protein-bound), Fasting vs. fed state, Individual variations in transporter expression, Age (may decline slightly with aging)

For Sleep Enhancement: 30-60 minutes before bedtime

For Cognitive Function: Morning or early afternoon

For Metabolic Health: With or before meals

For Muscle Recovery: Post-workout

With Other Supplements: Separate from other amino acids by 1-2 hours if possible for maximum absorption

Half Life: Approximately 0.5-1 hour in plasma

Metabolic Pathways: Incorporation into proteins, Conversion to serine via serine hydroxymethyltransferase, Catabolism via the glycine cleavage system, Utilization for glutathione synthesis, Conversion to creatine, Utilization for heme synthesis, Conjugation with bile acids, Direct excretion in urine (minor pathway)

Elimination Routes: Primarily metabolized; approximately 5-10% excreted unchanged in urine

Factors Affecting Clearance: Liver function (primary site of glycine metabolism), Kidney function (affects excretion of unchanged glycine), Metabolic demand (stress, illness may increase utilization), Age (metabolism may slow with aging), Genetic variations in glycine metabolizing enzymes

Degree Of Penetration: Moderate – glycine crosses the blood-brain barrier via specific transporters

Transport Mechanisms: Primarily via glycine transporters (GlyT1) at the blood-brain barrier

Factors Affecting Penetration: Blood-brain barrier integrity, Concentration gradient, Competition with other amino acids, Transporter saturation at high doses

Notes: Supplementation can increase CNS glycine levels, contributing to its neurological effects

Highest Concentrations: Collagen-rich tissues (skin, tendons, cartilage), Muscle tissue, Liver, Central nervous system (particularly spinal cord)

Lowest Concentrations: Adipose tissue, Blood plasma (tightly regulated)

Compartmentalization: Primarily intracellular; plasma levels represent only a small fraction of total body glycine

Tissue Specific Metabolism: Liver: primary site of glycine metabolism; CNS: utilized as neurotransmitter; Connective tissues: incorporated into collagen

Diurnal Patterns: Some evidence for diurnal variations in plasma glycine levels

Chronopharmacology: Evening administration appears particularly effective for sleep enhancement

Implications For Timing: Evening doses support sleep onset and quality; morning doses may support daytime cognitive function

With Medications: Limited known significant pharmacokinetic interactions, Theoretical interaction with clozapine (may affect seizure threshold), May enhance the effects of sedative medications through pharmacodynamic rather than pharmacokinetic mechanisms

With Other Supplements: Competing amino acids: reduced specific absorption when taken simultaneously, N-acetylcysteine: complementary for glutathione synthesis, Magnesium: complementary for sleep and relaxation effects

Clinical Significance: Generally low for most drug interactions; primarily pharmacodynamic rather than pharmacokinetic effects

Rating: 5 out of 5

Interpretation: Excellent safety profile with minimal risk of adverse effects even at high doses

Context: Extensive clinical use and research support safety across a wide dosage range; one of the safest amino acid supplements

Common Side Effects:

Rare Side Effects:

Long Term Side Effects:

• No well-established long-term adverse effects from glycine supplementation
• Potential metabolic adaptations with prolonged high-dose use; limited clinical significance
• No specific monitoring needed for most healthy individuals

Absolute Contraindications:

Relative Contraindications:

Major Interactions:

Moderate Interactions:

Minor Interactions:

Acute Toxicity:

• Not established in humans; animal studies suggest extremely low acute toxicity
• Primarily gastrointestinal symptoms: nausea, soft stools, abdominal discomfort
• Supportive care; symptoms typically resolve quickly

Chronic Toxicity:

• No Observed Adverse Effect Level not firmly established; doses up to 90 g/day have been used in clinical settings without serious adverse effects
• Minimal concerns for chronic toxicity based on available data
• No specific biomarkers established for monitoring; standard health monitoring sufficient

Upper Limit:

• No officially established upper limit by regulatory agencies
• Generally considered safe up to 90 g daily in divided doses for healthy adults under medical supervision
• Extremely high safety margin; typical therapeutic doses (3-5 g) are far below any potential toxicity threshold

Pediatric:

• Limited data outside of clinical settings; generally not recommended without medical supervision
• Developing nervous system; different amino acid requirements than adults
• Avoid supplementation unless specifically recommended by healthcare provider

Geriatric:

• Generally well-tolerated; may be particularly beneficial for sleep quality and cognitive function
• Potentially increased sensitivity to sedative effects
• Start at lower doses (2-3 g daily); gradually increase as tolerated

Pregnancy:

• Insufficient data for supplementation; classified as FDA Pregnancy Category C
• Potential unknown effects on fetal development
• Avoid supplementation unless specifically recommended by healthcare provider

Lactation:

• Insufficient data for supplementation
• Potential transfer to breast milk; unknown effects on infant
• Avoid supplementation unless specifically recommended by healthcare provider

Renal Impairment:

• Generally well-tolerated in mild to moderate impairment
• Altered amino acid clearance in severe impairment
• No specific dose adjustment needed for mild to moderate impairment; use with caution in severe impairment

Hepatic Impairment:

• Use with caution; liver is primary site of glycine metabolism
• Altered amino acid metabolism in severe impairment
• No specific dose adjustment needed for mild impairment; use with caution in moderate to severe impairment

Allergenicity Rating: Very low

Common Allergic Manifestations: Skin rash, itching (extremely rare)

Cross Reactivity: No known common cross-reactivities

Testing Methods: No standardized allergy testing available; typically diagnosed through elimination and challenge

Recommended Baseline Tests: None specifically required for most healthy individuals

Follow Up Monitoring: No specific monitoring required for most healthy individuals using recommended doses

Warning Signs To Watch: Unusual or persistent side effects; allergic reactions (extremely rare)

When To Discontinue: If significant side effects occur; if allergic reaction suspected

Glycine Powder:

• Potential for dosing errors with loose powder
• Allows for flexible dosing; typically free from additives
• Use accurate measuring tools; start with lower doses if uncertain

Glycine Capsules Tablets:

• May contain fillers, binders, or other additives that could cause sensitivity in some individuals
• Convenient; precise dosing
• Check ingredient list for potential allergens or problematic additives

Glycine In Protein Supplements:

• May contain other ingredients with their own safety profiles
• Provides glycine in context with other amino acids
• Consider total protein intake when using protein-based glycine sources

Handling Precautions: Standard precautions for food-grade materials; avoid inhalation of powder

Storage Safety: Store in cool, dry place in sealed containers

Disposal Considerations: No special disposal requirements for normal quantities

Hospital Use: Used in specialized clinical nutrition formulations; used in high doses for some neurological conditions

Documented Adverse Events: Very low incidence of adverse events in clinical settings, even at high doses

Safety In Medical Conditions: Generally well-tolerated across a range of medical conditions

Lessons From Clinical Use: High doses (30-60 g daily) have been used for schizophrenia with acceptable safety profile under medical supervision

Common Combinations:

• Generally safe; complementary effects for sleep
• Generally safe; complementary effects for relaxation
• Generally safe; complementary effects for sleep
• Generally safe; complementary for glutathione production

Combinations To Avoid:

• Caution advised due to potential additive effects
• Potentially counteracting effects

Reported Adverse Events: Very few serious adverse events reported; primarily mild gastrointestinal complaints

Population Level Safety Data: Extensive use in supplements and clinical settings supports excellent safety profile

Regulatory Actions: No significant regulatory actions or warnings specific to glycine supplementation

Emerging Safety Concerns: No significant emerging safety concerns identified

Vs Other Amino Acids: Generally safer than many other amino acid supplements; fewer known side effects and drug interactions

Vs Sleep Medications: Significantly better safety profile than most pharmaceutical sleep aids; non-habit forming

Vs Anti Inflammatory Agents: Better safety profile than NSAIDs and other anti-inflammatory medications

Vs Cognitive Enhancers: Better safety profile than many nootropics and cognitive enhancers

Pre Workout Considerations: May cause mild drowsiness in some individuals; typically not used pre-workout

During Activity Considerations: No specific safety concerns during activity

Post Workout Considerations: Safe for post-workout recovery; no known negative effects on exercise adaptation

Longest Clinical Studies: Studies up to 6-12 months show continued safety

Animal Model Data: Long-term animal studies show excellent safety profile

Theoretical Long Term Concerns: No significant theoretical concerns for long-term use based on mechanism of action and metabolism

Recommendations For Cycling: No evidence suggesting need for cycling; can be taken continuously

Mhlw Status: Classification: May be used in Foods with Health Claims, including Foods with Nutrient Function Claims (FNFC) and Foods for Specified Health Uses (FOSHU), Specific Regulations: Subject to regulations under the Health Promotion Law, Approved Uses: Array, Restrictions: Specific approved products have defined formulations and claims, Classification: Designated food additive, Specific Regulations: Listed in the List of Designated Food Additives, Approved Uses: Array, Restrictions: Must comply with Japanese food additive regulations

Production Significance: Major global producer of glycine through companies like Ajinomoto

Nmpa Status: Classification: May be registered as a Health Food, Specific Regulations: Subject to registration or filing under Health Food regulations, Approved Uses: Array, Restrictions: Specific approved products have defined formulations and claims, Registration Process: Requires extensive safety and efficacy data for registration, Classification: Permitted food additive, Specific Regulations: Listed in the National Food Safety Standard for Food Additives (GB 2760), Approved Uses: Array, Restrictions: Must comply with Chinese food additive regulations

Production Significance: Major global producer of glycine; significant manufacturing capacity

Relative Cost Category: Low

Price Range Comparison: Less expensive than most amino acid supplements; significantly less expensive than many sleep aids and cognitive enhancers

Market Trends: Stable pricing with slight increases due to growing popularity for sleep applications

Production Scale Impact: Large-scale industrial production keeps costs relatively low; economies of scale benefit standard glycine products

Glycine represents excellent value for its primary applications, particularly sleep enhancement, with powder forms offering the best cost-effectiveness. The cost-to-benefit ratio is most favorable for sleep quality improvement, where 3 grams before bedtime (costing approximately $0.06-0.20 daily) has demonstrated benefits in multiple clinical studies. This makes glycine one of the most cost-effective sleep-supporting supplements available, with a better safety profile than many alternatives. For cognitive function and metabolic health, the value proposition remains strong though the evidence base is less robust.

The wide range of pricing across different forms creates opportunities for consumer savings, with bulk powder purchases offering up to 80% cost reduction compared to specialized formulations. While convenience forms like capsules and combination products command premium prices, the basic powder’s mild taste makes it palatable for most users. Overall, glycine supplementation offers exceptional economic value, particularly for sleep applications, with costs significantly lower than both natural and pharmaceutical alternatives offering similar benefits.

Appearance: White crystalline powder in pure form; should remain free-flowing and white when properly stored

Solubility: Highly soluble in water (approximately 25g/100mL at 25°C); practically insoluble in ethanol and other organic solvents

Hygroscopicity: Low to moderate hygroscopicity; can absorb moisture from humid environments but less hygroscopic than many amino acids

Particle Characteristics: Typically crystalline powder; particle size affects dissolution rate and flow properties

Physical Changes Over Time: May develop slight clumping if exposed to moisture; generally stable in solid form when properly stored

Temperature Excursions: Generally tolerant of short-term temperature excursions during shipping

Vibration Effects: Minimal impact; may cause some powder compaction

Protective Measures: Standard pharmaceutical shipping practices sufficient; additional moisture protection for international shipping

International Shipping Considerations: Avoid extreme temperature exposure; use moisture-protective packaging for sea freight

With Vitamins: Generally compatible with most vitamins; minimal interaction concerns

With Minerals: Forms stable complexes with many minerals; generally good compatibility

With Botanicals: Generally compatible; specific interactions depend on the botanical components

With Other Amino Acids: Generally compatible in dry formulations; competitive absorption in solution

With Probiotics: Compatible in dry formulations; limited data on interactions

Synthesis Methods

Natural Sources

Quality Considerations

Sourcing Recommendations

Market Information

Dietary Considerations

First Isolation: Glycine was first isolated from gelatin in 1820 by French chemist Henri Braconnot, who initially named it ‘glycocolle’ (sweet glue) due to its sweet taste.

Naming Origin: The name ‘glycine’ derives from the Greek word ‘glykys’ meaning ‘sweet,’ reflecting its mildly sweet taste. The name was formally adopted in 1858, replacing the earlier term glycocolle.

Structural Determination: Its chemical structure as the simplest amino acid (NH₂CH₂COOH) was determined in the mid-19th century, with its complete characterization as an amino acid established by the early 20th century.

Key Researchers: Henri Braconnot (first isolation from gelatin in 1820), Jean-Baptiste Boussingault (identified glycine as a component of various proteins in the 1830s), Edward Frankland and B.F. Duppa (contributed to structural understanding in the 1860s), Albrecht Kossel (work on amino acids including glycine in the late 19th century), Emil Fischer (pioneering work on amino acid chemistry in the early 20th century)

Rating: 3 out of 5

Interpretation: Moderate evidence supporting specific applications; growing research base

Context: Strong evidence for sleep quality improvement and certain metabolic effects; moderate evidence for cognitive and anti-inflammatory benefits; emerging evidence for other applications

Sleep Applications: Good consensus supporting use for sleep quality improvement at 3g before bedtime

Metabolic Applications: Growing consensus supporting potential benefits for metabolic health, particularly in individuals with existing metabolic disorders

Cognitive Applications: Mixed opinions on effectiveness for cognitive enhancement in healthy individuals; more agreement on potential benefits in specific neurological conditions

Safety Assessment: Strong consensus on excellent safety profile across a wide dosage range

Research Priorities: Focus on long-term effects, optimal dosing for different applications, and clarification of mechanisms

Early Research: Initial focus on basic biochemistry and role in protein structure in early-mid 20th century

Middle Period: Discovery of neurotransmitter role and initial clinical applications in 1960s-1990s

Recent Developments: Expanded research into sleep, metabolic health, and neuroprotection since 2000s; growing interest in clinical applications

Vs Other Sleep Aids: Generally fewer side effects than pharmaceutical sleep medications; may be less potent than some but offers better safety profile and no dependency risk; comparable efficacy to some natural sleep aids like melatonin for certain sleep parameters

Vs Other Amino Acids: More evidence for sleep benefits than most amino acids; comparable evidence for metabolic effects to some amino acids; unique profile combining inhibitory neurotransmitter effects with structural and metabolic roles

Vs Anti Inflammatory Agents: Milder effects than pharmaceutical anti-inflammatories but better safety profile; may be complementary rather than alternative to conventional treatments

Cost Effectiveness Analysis: Excellent cost-effectiveness for sleep applications; moderate to good for metabolic applications; limited data for other applications